About Stiff-Person Syndrome
SPS is caused by antibodies attacking proteins in the brain neurons that control muscle movements.
Non-modifiable risk factors for SPS are factors that cannot be changed. These include:
- Genetic predisposition
- Personal or family history of systemic autoimmune conditions
There are currently no known modifiable risk factors for SPS. SPS is an autoimmune disorder for which there are no lifestyle changes or preventive measures that can directly reduce the risk of developing the disease.
If you have concerns about your risk for stiff-person syndrome it is best to consult with your healthcare professional for personalized advice and guidance.
The most common early symptoms of stiff person syndrome include:
- Stiffness in the muscles of the trunk, arms, and legs
- Posture problems from rigid back muscles
- Painful muscle spasms
- Walking difficulties
- Sensitivity to light, noise, and sound
In later stages or with higher severity of SPS, individuals may experience increased muscle stiffness and rigidity affecting other body parts, such as the face muscles used for eating and talking.
As the condition progresses, emotional distress like anxiety and depression may occur due to symptoms or changes in brain neurotransmitters.
To diagnose SPS, doctors typically start by examining the individual's medical history and performing a physical exam. Other tests and procedures commonly performed include:
- Electromyography (EMG): This is a common test used to measure muscular electrical activity.
- Blood tests to detect elevated levels of antibodies
- Lumbar puncture to analyze cerebrospinal fluid and further confirm the diagnosis
To determine the stage or severity of stiff person syndrome, doctors may also conduct imaging studies like MRI scans to assess any structural changes in the brain or spinal cord that could indicate disease progression.
Remember that these are general guidelines, and your healthcare provider will determine which specific examinations, tests, and procedures are necessary based on your individual situation.
The goals of treatment for SPS aim to reduce muscle stiffness, spasms, and pain, allowing for improved movement and quality of life. Treatment options for SPS include:
- Medications such as benzodiazepines and muscle relaxants to help ease muscle stiffness and spasms.
- Therapeutic procedures such as intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibodies. These therapies may be recommended to modulate the immune system's response in autoimmune-related cases of SPS.
- Physical therapy.
- Self-care and health behavior changes: Joining a support group or seeking support from family and friends may help provide support needed to cope with SPS.
It’s important to note that medications may have side effects that should be considered.
Treatment decisions should be individualized based on patient characteristics and goals. Remember to consult with your healthcare professional before starting any new medication or treatment plan.
SPS is a rare neurological disorder that can progress over time. Initially, individuals may experience muscle stiffness, rigidity, and painful spasms in the trunk, arms, and legs. As the condition advances, some people may develop severe hunching of the spine that affects their posture and mobility.
Complications of SPS include increased disability. People with SPS may have difficulty walking or moving, leading to an increased risk of falls and injuries. The heightened sensitivity to noise, touch, and emotional stress can trigger muscle spasms, making individuals more prone to accidents.
While treatment can help reduce symptoms and enhance mobility for many individuals with SPS, it's essential to note that there is currently no cure for the condition. The impact of treatment varies from person to person, with some experiencing improved walking patter, reduced spasms, and better balance. However, for some individuals, the benefits of treatment may diminish over time as the disease progresses, highlighting the ongoing need for more effective therapies in managing SPS.